Genocea Biosciences, Inc.
Biotechnology company · Cambridge, Massachusetts, United States
Genocea Biosciences, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2006. It has reported private securities offerings to the US SEC, most recently $76 million sold in a notice filed in 2020.
Genocea Biosciences at a glance
What does Genocea Biosciences do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $75.5 million sold (2020).
Frequently asked questions about Genocea Biosciences
Where is Genocea Biosciences headquartered?
Genocea Biosciences, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Genocea Biosciences do?
Genocea Biosciences, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
When was Genocea Biosciences founded?
The earliest incorporation on record for Genocea Biosciences, Inc. is in 2006, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences